Diabetes Therapy

Alliance to identify factors important to stem cell differentiation

Published in Obesity and Diabetes Week, June 28th, 2004

Athersys has received a grant from the Juvenile Diabetes Research Foundation (JDRF) to fund research through its new JDRF-Industry Discovery and Development Partnership Program that will focus on identifying proteins that promote the formation of pancreatic islet cells.

Under the terms of the agreement, company researchers will apply Athersys' two proprietary technologies, the RAGE (Random Activation of Gene Expression) platform and MAPC (Multipotent Adult Progenitor Cell) technology - a novel adult-derived stem cell originally discovered by Catherine Verfaillie and her colleagues at the University of Minnesota.

Research conducted by Verfaillie and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2004-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry